Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...

A medical expert explained the non-pharmaceutical ways to lower cholesterol levels after a patient said they didn't like the ...

NEW research employing Mendelian randomisation (MR) analysis has identified a potential causal relationship between lipid ...

Q: Why did my primary care physician tell me that in order to dodge osteoporosis, which my mom and grandmother have, I need ...

People in the UAE with a specific genetic variant are at greater risk from air pollution than those without it, a study has ...

Researchers investigated the potential association between plasma apolipoprotein M (APOM) levels and the risk of adverse ...

A team of Ohio University researchers have made a groundbreaking development in the fight against obesity. In a study ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

In this randomized controlled trial, among patients with persistent chylomicronemia, it was found that plozasiran more ...

"Cytotoxic agents from nature lead to an increased incorporation of polyunsaturated fatty acids into the membrane of cancer cells. This makes them more susceptible to ferroptosis, a type of cell ...